Chronic Health

Data Snapshot: May 05, 2024
Chronic Health Cannabis Brand Logo
$50K+

Apr-2024

Sales

Decline

Trend

6-Month

25

Product Count

SKUs

Chronic Health

Overview

Chronic Health presents itself as a brand focused on offering cannabis-related products for the alleviation of several persistent and severe health conditions such as Crohn's disease, chronic pain, and Multiple Sclerosis. Despite the fact that the FDA has yet to approve the cannabis plant for medicinal use, there is a growing trend towards recognizing its potential benefits, especially for those with chronic ailments who may find extended relief beneficial in everyday environments like the workplace. However, given the concerns regarding limited research on long-term impacts of "medical marijuana" use, Chronic Health operates amidst a duality of growing acceptance and ongoing scientific scrutiny.
Markets

Chronic Health Locations

Product Trends

Chronic Health Categories

Chronic Health Sales

Market Insights Snapshot

Chronic Health Historical Sales by Category

In the Arizona market, Chronic Health has shown a consistent performance in the Tincture & Sublingual category, maintaining a second-place ranking across January, February, March, and April 2024. This stability is noteworthy, especially in a competitive market like Arizona's cannabis scene. However, the sales figures indicate a decreasing trend from January's high of $26,525 to $19,505 in April, suggesting a potential area for the brand to address. In contrast, the Topical category presents a more volatile journey for Chronic Health, with rankings fluctuating between the second and sixth positions during the same period. Despite this, March saw a significant peak in sales ($49,712), hinting at a strong market presence but also pointing towards the need for strategic adjustments to maintain or improve their market position consistently.

The performance variation between categories for Chronic Health in Arizona highlights different market dynamics and consumer preferences impacting the brand's standings. The steady rank in the Tincture & Sublingual category could reflect a loyal customer base or effective product positioning that resonates well with the market's needs. On the other hand, the fluctuating rankings in the Topical category underscore the competitive challenges and perhaps the greater sensitivity to market changes or consumer trends in this segment. These insights suggest that while Chronic Health has a strong foothold in Arizona's cannabis market, especially within the Tincture & Sublingual category, there is room for growth and improvement, particularly in leveraging the highs and addressing the lows in the Topical category to achieve more consistent performance.

Apr-2024 Rank
Tincture & Sublingual
Topical
2
6
Chronic Health

Competitive Landscape

In the competitive landscape of the topical cannabis market in Arizona, Chronic Health has experienced fluctuations in its ranking over the first four months of 2024, indicating a volatile position among its competitors. Starting strong in January as the second-ranked brand, it saw a decline to fifth in February, a slight improvement to fourth in March, but then dipped to sixth by April. This trajectory suggests that despite a strong start to the year, Chronic Health faces significant challenges in maintaining its market position. Notably, Tru Infusion has shown remarkable performance, not ranked in January but swiftly climbing to third by February and securing the second spot in March and fourth in April, demonstrating a more robust upward trend in both rank and sales. Meanwhile, Müv / MUV has consistently performed well, maintaining a top five presence throughout the same period, which underscores the competitive pressure on Chronic Health. On the other hand, DermaFreeze, while remaining in the seventh spot, has seen steady sales growth, hinting at a potential challenge to higher-ranked brands, including Chronic Health, if this growth continues. This analysis underscores the need for Chronic Health to innovate and adapt its strategies to not only reclaim but also secure a higher market position amidst fierce competition.

Chronic Health market ranking for AZ Topical

Chronic Health

Notable Products

In April 2024, Chronic Health saw the CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC) as its top-selling product, maintaining its position from March with sales figures reaching 266 units. Following closely, the CBD/THC 1:1 Pain Relief Roll-On (50mg CBD, 50mg THC) secured the second spot, showing consistent performance since February. The third place was claimed by the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz), which rose from its previous third-place ranking in March, indicating a growing interest in tincture products. Interestingly, the Indica Pain Relief Ointment (80mg THC, 0.5oz) made a comeback in the rankings at fourth place, despite not being ranked in the previous two months. The CBD/THC 1:1 Pain Relief Ointment (40mg CBD, 40mg THC) experienced a slight decline, moving from the top position in February to fifth in April, highlighting a shift in consumer preferences within Chronic Health's product lineup.

Product Rank
Category
Jan-2024
Feb-2024
Mar-2024
Apr-2024
CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC)
Topical
1
4
1
1
CBD/THC 1:1 Pain Relief Roll-On (50mg CBD, 50mg THC)
Topical
>5
2
2
2
CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz)
Tincture & Sublingual
2
5
3
3
Indica Pain Relief Ointment (80mg THC, 0.5oz)
Topical
4
>5
>5
4
CBD/THC 1:1 Pain ReLief Ointment (40mg CBD, 40mg THC)
Topical
3
1
4
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.
Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data